CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with stage I-IIIA Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before sur ...
Phase 2
San Francisco, California, United States and 2 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...
Phase 1
Stanford, California, United States and 25 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
Santa Rosa, California, United States and 137 other locations
body radiation therapy (SBRT) in treating patients with stage I non-small cell lung cancer that cannot b ...
Phase 1
Travis Air Force Base, California, United States and 1 other location
of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...
Phase 3
Santa Rosa, California, United States and 168 other locations
in combination with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or ho....
Phase 1
San Francisco, California, United States and 23 other locations
checkpoint inhibitor therapy (CkIT) in patients with advanced NSCLC tumors at multiple study sites. The main objectives of the study are to ...
Phase 2
Palo Alto, California, United States and 2 other locations
Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) t...
Phase 2
San Francisco, California, United States and 33 other locations
alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...
Phase 3
Santa Rosa, California, United States and 153 other locations
, early-stage non-small cell lung cancer....
Phase 2
Oakland, California, United States and 94 other locations
Clinical trials
Research sites
Resources
Legal